Repository logo
 
Publication

Optical fiber bioanalyzer based on enzymatic coating matrix for catecholamines and their metabolites assessment in patients with down syndrome

dc.contributor.authorSilva, Lurdes I. B.
dc.contributor.authorGomes, A. M.
dc.contributor.authorPintado, M. M.
dc.contributor.authorPinheiro, H.
dc.contributor.authorMoura, D.
dc.contributor.authorFreitas, Ana C.
dc.contributor.authorRocha-Santos, Teresa A. P.
dc.contributor.authorPereira, M. E.
dc.contributor.authorDuarte, A. C.
dc.date.accessioned2013-01-28T10:41:29Z
dc.date.available2013-01-28T10:41:29Z
dc.date.issued2012
dc.description.abstractThe urinary levels of catecholamines [adrenaline (AD), noradrenaline (NA), and dopamine (DA)] and their metabolites [L-3,4-dihydroxyphenylalanine (L-DOPA), and 3,4-dihydroxyphenylacetic acid (DOPAC)], as indicators of physiological stress, were assessed in 40 patients with Down syndrome (DS). The analysis was performed by an optical fiber (OF) bioanalyzer; which was constituted by two main components: a miniaturized chromatographic system and a detection system based on an OF coated with an enzymatic matrix. In this study some working conditions such as, number of fibers in the miniaturized chromatographic column, number of dips for sensitive coating deposition, temperature and time of cure of the sensitive matrix, were optimized in order to achieve higher analytical performance. After tested for calibration the bioanalyzer was applied to urine samples analysis of catecholamines and their metabolites, comparing the results with those obtained by both, a classical analytical method, namely high performance liquid chromatography coupled to an electrochemical detector (HPLC-ED), and an OF biosensor based on a sensitive cladding of laccase (LacOF biosensor). The results of catecholamines in patients with DS revealed that 15% and 22.5% of the analyzed subjects showed DA and AD concentrations, respectively, above the pathological levels. In the determinations of NA, the 40 samples showed concentration values below the normal levels, while in the determination of catecholamines metabolites 5% of the urine samples showed values above 118 and 1681 for L-DOPA and DOPAC, respectively. Index Terms—Catecholamines analysis, down syndrome, HPLC-ED, OF bioanalyzer.por
dc.description.versioninfo:eu-repo/semantics/publishedVersion
dc.identifier.citationSILVA, Lurdes I. B... [et al.] - Optical Fiber Bioanalyzer Based on Enzymatic Coating Matrix for Catecholamines and Their Metabolites Assessment in Patients With Down Syndrome. IEEE Sensors Journal. ISSN 1530-437X. Vol. 12, n.º 1 (2012), p. 76-84por
dc.identifier.doi10.1109/JSEN.2011.2127471
dc.identifier.eissn1558-1748
dc.identifier.issn1530-437X
dc.identifier.urihttp://hdl.handle.net/10400.14/9958
dc.identifier.wosWOS:000297631700013
dc.language.isoengpor
dc.peerreviewedyespor
dc.publisherIEEEpor
dc.titleOptical fiber bioanalyzer based on enzymatic coating matrix for catecholamines and their metabolites assessment in patients with down syndromepor
dc.typejournal article
dspace.entity.typePublication
oaire.citation.endPage84
oaire.citation.issue1
oaire.citation.startPage76
oaire.citation.titleIEEE Sensors Journal
oaire.citation.volume12
person.familyNameGomes
person.familyNamePintado
person.familyNamePinheiro
person.familyNameMoura
person.familyNameCardoso Freitas Lopes de Freitas
person.familyNameRocha-Santos
person.familyNamePereira
person.familyNameDuarte
person.givenNameAna Maria
person.givenNameMaria Manuela
person.givenNameHelder
person.givenNameDaniel
person.givenNameAna Cristina
person.givenNameTeresa
person.givenNameEduarda
person.givenNameArmando
person.identifier162628
person.identifier456608
person.identifier158867
person.identifier.ciencia-idAA12-BFC1-B2E3
person.identifier.ciencia-id2F13-AAE0-3405
person.identifier.ciencia-idFA13-B4AD-4BBB
person.identifier.ciencia-id7F10-545A-7D05
person.identifier.ciencia-id2D1C-3C88-7AE4
person.identifier.ciencia-id1815-0F9A-720E
person.identifier.ciencia-id6F14-D930-774A
person.identifier.orcid0000-0001-7883-2446
person.identifier.orcid0000-0002-0760-3184
person.identifier.orcid0000-0001-6076-2670
person.identifier.orcid0000-0003-3848-3362
person.identifier.orcid0000-0002-1430-9370
person.identifier.orcid0000-0003-3660-4116
person.identifier.orcid0000-0002-6046-5243
person.identifier.orcid0000-0002-4868-4099
person.identifier.ridB-9944-2013
person.identifier.ridF-5696-2013
person.identifier.ridA-2355-2009
person.identifier.ridC-1424-2008
person.identifier.scopus-author-id57190668768
person.identifier.scopus-author-id7004483898
person.identifier.scopus-author-id36931506900
person.identifier.scopus-author-id7005556838
person.identifier.scopus-author-id35235205100
person.identifier.scopus-author-id7202834182
person.identifier.scopus-author-id7102601994
rcaap.rightsrestrictedAccesspor
rcaap.typearticlepor
relation.isAuthorOfPublicationc18c2fb1-f3dc-4274-a646-23d456432798
relation.isAuthorOfPublicationba387c7d-27c9-4016-895c-b35597e91ebc
relation.isAuthorOfPublication1820a373-6184-498c-a859-17a6087fa366
relation.isAuthorOfPublicationb6aeeab9-aa3e-41e0-a776-d799d599d2d6
relation.isAuthorOfPublication60894705-709d-4186-9777-ac557e723b83
relation.isAuthorOfPublication7f35088d-8aaf-4f3e-9b5e-e0ee198443e0
relation.isAuthorOfPublicatione82da766-93a0-44ce-b21e-93e525c283d7
relation.isAuthorOfPublication41893298-81c6-41ef-8b2c-eedf31618ddb
relation.isAuthorOfPublication.latestForDiscoveryc18c2fb1-f3dc-4274-a646-23d456432798

Files

Original bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
AI70.pdf
Size:
920.92 KB
Format:
Adobe Portable Document Format
License bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
3.44 KB
Format:
Item-specific license agreed upon to submission
Description: